Mohlo by se vám také líbit

Více informací o knize FDA Bioequivalence Standards

• Parametry knihy
• Anotace
• Oblíbené z jiného soudku

Nákupem získáte 541 bodů

Anotace knihy

This comprehensive reference provides an in-depth discussion on state-of-the-art regulatory science in bioequivalence. In sixteen chapters, the volume explores a broad range of topics pertaining to bioequivalence, including its origin and principles, statistical considerations, food effect studies, conditions for waivers of bioequivalence studies, Biopharmaceutics Classification Systems, Biopharmaceutics Drug Disposition Classification System, bioequivalence modeling/simulation and best practices in bioanalysis. It also discusses bioequivalence studies with pharmacodynamic and clinical endpoints as well as bioequivalence approaches for highly variable drugs, narrow therapeutic index drugs, liposomes, locally acting gastrointestinal drug products, topical products and nasal and inhalation products.§FDA Bioequivalence Standards is written by FDA regulatory scientists who develop regulatory policies and conduct regulatory assessment of bioequivalence. As such, both practical case studies and fundamental science are highlighted in these chapters. The book is a valuable resource for scientists who work in the pharmaceutical industry, regulatory agencies and academia as well as undergraduate and graduate students looking to expand their knowledge about bioequivalence standards. §

Parametry knihy

Zařazení knihy Knihy v angličtině Technology, engineering, agriculture Industrial chemistry & manufacturing technologies Industrial chemistry

• Plný název: FDA Bioequivalence Standards
• Autor: Bing V. Li, Lawrence X. Yu
• Jazyk: Angličtina
• Vazba: Pevná
• Počet stran: 465
• EAN: 9781493912513
• ISBN: 1493912518
• ID: 02723205
• Nakladatelství: Springer-Verlag New York Inc.
• Hmotnost: 812 g
• Rozměry: 162 × 243 × 24 mm
• Datum vydání: 06. September 2014

Oblíbené z jiného soudku

---

---

---